Artificial and other non-nutritive sweeteners generally do not produce a meaningful acute insulin or glucose spike on their own. They may modestly help with weight control when they replace sugar, but long-term observational studies remain harder to interpret.
Practical Health Science Editorial Team
6 min read
Sep 4, 2026
Continuous glucose monitors are increasingly marketed to people without diabetes as tools for personalized nutrition and metabolic health. They can reveal glucose patterns and may encourage behavior change, especially in people at higher metabolic risk. But for healthy adults, evidence that CGMs improve long-term health remains limited.
Practical Health Science Editorial Team
9 min read
Sep 3, 2026
People who are more physically active have a lower risk of several cancers, including breast, colon, endometrial, kidney, and bladder cancer. Exercise may help through multiple biological pathways, but it cannot eliminate cancer risk.
Practical Health Science Editorial Team
6 min read
Sep 2, 2026
Inflammation is a normal immune response to injury, infection, and cellular stress. Acute inflammation helps protect and repair tissues, while persistent low grade inflammation can contribute to chronic disease.
Practical Health Science Editorial Team
6 min read
Sep 1, 2026
Intermittent fasting is an effective weight-loss strategy, but most research does not show a major advantage over conventional calorie restriction. The best approach may be the one you can actually maintain.
Practical Health Science Editorial Team
7 min read
Sep 1, 2026
Walking after a meal can reduce the short-term rise in blood glucose, especially compared with remaining seated. The effect is real, although its long-term importance depends on your overall activity and metabolic health.
Practical Health Science Editorial Team
6 min read
Sep 1, 2026
Insulin resistance happens when tissues such as muscle, liver, and fat respond less effectively to insulin. Blood sugar may remain normal for years while the pancreas compensates by producing more insulin.
Practical Health Science Editorial Team
6 min read
Sep 1, 2026
GLP-1 weight-loss drugs can reduce lean mass along with fat. But most of the weight lost is fat, and current evidence does not show that lean-mass loss automatically translates into muscle weakness or pathological muscle wasting.
Practical Health Science Editorial Team
6 min read
Aug 31, 2026